Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

237.72

+7.70 (3.35%)

At close: Jun 29, 2026, 4:00 PM EDT

236.98

-0.74 (-0.31%)

Pre-market: Jun 30, 2026, 7:59 AM EDT

Jazz Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,844	1,392	2,413	1,506	881.48	591.45
Short-Term Investments	1,030	1,050	580	120	-	-
Cash & Short-Term Investments	2,874	2,442	2,993	1,626	881.48	591.45
Cash Growth	11.76%	-18.41%	84.03%	84.50%	49.04%	-59.33%
Accounts Receivable	836.3	830.75	716.77	705.79	651.49	563.36
Inventory	437.5	416.96	480.45	597.04	714.06	1,073
Other Current Assets	435	476.44	438.95	506.29	359.1	383.81
Total Current Assets	4,583	4,166	4,629	3,435	2,606	2,611
Net Property, Plant & Equipment	258.9	258.74	227	234.99	301.38	343.42
Other Intangible Assets	4,204	4,430	4,756	5,418	5,794	7,152
Goodwill	1,805	1,829	1,716	1,753	1,693	1,828
Other Long-Term Assets	1,009	975.71	684.22	551.78	440.64	363.95
Total Assets	11,860	11,659	12,012	11,393	10,835	12,299
Accounts Payable	100	122.06	77.87	102.75	90.76	100.3
Accrued Expenses	1,022	1,034	910.95	793.91	803.26	666.3
Current Portion of Long-Term Debt	1,031	1,030	31	604.95	31	31
Unearned Revenue	-	-	-	-	0.46	2.09
Other Current Liabilities	93.7	56.39	18.76	35.07	7.72	9.61
Total Current Liabilities	2,247	2,243	1,039	1,537	933.19	809.3
Long-Term Debt	4,324	4,328	6,078	5,108	5,693	6,019
Long-Term Leases	47.3	50.89	38.94	59.23	71.84	87.2
Other Long-Term Liabilities	709.2	718.99	763.35	952.46	1,051	1,418
Total Long-Term Liabilities	5,081	5,098	6,880	6,120	6,816	7,524
Total Liabilities	7,327	7,341	7,919	7,656	7,750	8,333
Common Stock	0.6	0.53	0.53	0.53	0.53	0.53
Additional Paid-in Capital	4,244	4,240	3,914	3,700	3,477	3,535
Accumulated Other Comprehensive Income	-651	-568.6	-947.67	-842.15	-1,126	-400.36
Retained Earnings	939.2	646.18	1,127	878.66	733.59	830.23
Shareholders' Equity	4,532	4,319	4,094	3,737	3,086	3,965
Total Liabilities & Equity	11,860	11,659	12,012	11,393	10,835	12,299
Total Debt	5,402	5,409	6,148	5,772	5,796	6,137
Net Cash (Debt)	-2,528	-2,967	-3,155	-4,146	-4,915	-5,546
Net Cash Per Share	-40.07	-48.66	-47.79	-57.53	-78.59	-92.90
Book Value	4,532	4,319	4,094	3,737	3,086	3,965
Book Value Per Share	71.85	70.82	62.02	51.86	49.34	66.43
Tangible Book Value	-1,477	-1,940	-2,378	-3,434	-4,401	-5,015
Tangible Book Value Per Share	-23.41	-31.82	-36.03	-47.65	-70.38	-84.01

SEC Filings: 10-K · 10-Q